Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- GBX | -.--% | -10.17% | -.--% |
Mar. 28 | European Equities Traded in the US as American Depositary Receipts Slightly Higher Thursday | MT |
Mar. 28 | Needham Adjusts Price Target on Mereo BioPharma to $6 From $5, Keeps Buy Rating | MT |
Chart calendar Mereo BioPharma Group plc
Upcoming events on Mereo BioPharma Group plc
Past events on Mereo BioPharma Group plc
2024-03-26 | Q4 2023 Earnings Release (Projected) |
2024-03-12 11:20 am | Leerink Partners Global Biopharma Conference - Fireside Chat |
2023-10-19 | European Society for Medical Oncology Congress |
2023-09-27 10:55 am | Cantor Global Healthcare Conference - Fireside Chat |
2023-09-07 07:30 am | Q2 2023 Earnings Release |
2023-06-08 09:30 am | Jefferies Global Healthcare Conference |
2023-05-23 09:00 am | American Thoracic Society International Conference - Abstract No 10172 |
2023-05-22 09:00 am | American Thoracic Society International Conference - Abstract No 10358 |
2023-04-20 08:45 am | Needham Healthcare Conference |
2023-03-28 04:30 pm | Q4 2022 Earnings Release |
2023-03-21 08:30 am | Business Update Call |
2023-02-15 08:00 am | SVB Securities Global Biopharma Conference |
2022-11-18 09:00 am | Extraordinary Shareholders Meeting - Proxy Fight for Board Representation |
2022-11-15 07:55 am | Jefferies London Healthcare Conference - Fireside Chat |
2022-10-31 08:00 am | R&D Day |
2022-06-05 09:00 am | American Society of Clinical Oncology Meeting - Abstract No. 2651 |
2022-05-09 10:30 am | ASTRAEUS Phase 2 Clinical Study Results Call |
2022-04-13 12:45 pm | Needham Virtual Healthcare Conference |
2022-03-31 04:01 pm | FY 2021 Earnings Release |
2022-03-14 10:00 am | R&D Day |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million GBP | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 36,5 24,3 49.93% | 0,00 0,00 - | 10,0 7,93 26.18% | 0,00 |
EBITDA Million GBP | Released Forecast Spread | 0,00 0,00 - | -36,0 -34,9 -3.06% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million GBP | Released Forecast Spread | -39,5 -38,3 -3.1% | -37,6 -35,3 -6.43% | -20,9 -36,6 42.8% | -43,6 -43,3 -0.69% | -28,4 -27,9 -2.03% | -37,6 |
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -41,1 -40,5 -1.44% | -166 -145 -14.66% | 14,2 -8,10 275.9% | -36,1 -42,1 14.33% | -30,0 -28,2 -6.31% | -32,8 |
Net income Million GBP | Released Forecast Spread | -34,8 -39,2 11.19% | -164 -143 -14.25% | 12,7 -9,31 236.74% | -34,2 -41,4 17.38% | -29,5 -27,9 -5.43% | -32,8 |
EPS GBP | Released Forecast Spread | 0,00 0,00 - | -2,41 -0,52 -363.46% | 0,02 -0,02 252.67% | -0,06 -0,07 14.29% | -0,04 -0,04 5.88% | -0,05 |
Announcement Date | 15/06/20 | 31/03/21 | 31/03/22 | 28/03/23 | 27/03/24 | - |
Quarterly results
Fiscal Period | December | 2019 S1 | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 Q4 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million GBP | Released Forecast Spread | 0,00 0,00 - | 0,00 3,20 - | 0,00 0,00 - | 36,5 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 0,00 - | 7,13 0,00 - | 2,87 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | |
EBIT Million GBP | Released Forecast Spread | -21,1 -18,9 -11.83% | -16,7 -18,1 7.78% | -20,9 -16,9 -23.54% | -0,20 -18,0 98.87% | -10,4 -16,0 35.19% | -20,7 -19,0 -9.12% | -21,8 -18,8 -16.01% | -21,8 -20,1 -8.25% | -9,91 -11,0 9.92% | -18,5 -18,0 -3.1% | -18,0 | -19,5 | |||||||
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -22,4 -18,9 -18.71% | -126 -18,1 -596.69% | -40,3 -16,9 -138.75% | 10,9 -18,0 160.58% | -16,0 | 3,34 -19,0 117.56% | -19,9 -19,0 -4.7% | -16,2 -20,3 20.2% | -11,9 -11,0 -8.52% | -18,1 -16,3 -10.8% | -16,0 | -16,8 | -15,0 | -15,0 | |||||
Net income Million GBP | Released Forecast Spread | -16,2 | -18,6 -18,9 1.48% | -125 -18,1 -588.5% | -39,0 -16,9 -130.82% | 12,1 -18,0 167.16% | -16,0 | 0,64 -20,8 103.06% | -19,2 -19,0 -0.83% | -15,0 -20,7 27.24% | -11,0 -14,2 22.32% | -18,4 -17,3 -6.57% | -16,0 | -16,8 | -15,0 | -15,0 | ||||
EPS GBP | Released Forecast Spread | -0,35 -0,05 -600% | 0,02 -0,03 174.33% | -0,17 -0,03 -466.67% | 0,00 -0,05 101.38% | -0,03 -0,04 14.29% | -0,03 -0,04 18.19% | -0,02 -0,02 14.27% | -0,02 -0,03 27.27% | -0,03 | -0,03 | -0,02 | -0,02 | |||||||
Announcement Date | 17/09/19 | 15/06/20 | 29/09/20 | 31/03/21 | 02/11/21 | 31/03/22 | 31/03/22 | - | 02/11/22 | 02/11/22 | - | - | 28/03/23 | 07/09/23 | 27/03/24 | - | - | - | - |
Past sector events for Mereo BioPharma Group plc
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock Mereo BioPharma Group plc
- Stock Mereo BioPharma Group plc - London S.E.
- Calendar Mereo BioPharma Group plc